These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26961283)

  • 1. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
    Cerón-Romero L; Paoli P; Camici G; Flores-Morales V; Rios MY; Ramírez-Espinosa JJ; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2018-22. PubMed ID: 26961283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursolic acid derivatives as potential antidiabetic agents: In vitro, in vivo, and in silico studies.
    Guzmán-Ávila R; Flores-Morales V; Paoli P; Camici G; Ramírez-Espinosa JJ; Cerón-Romero L; Navarrete-Vázquez G; Hidalgo-Figueroa S; Yolanda Rios M; Villalobos-Molina R; Estrada-Soto S
    Drug Dev Res; 2018 Mar; 79(2):70-80. PubMed ID: 29380400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
    Ramírez-Espinosa JJ; Rios MY; López-Martínez S; López-Vallejo F; Medina-Franco JL; Paoli P; Camici G; Navarrete-Vázquez G; Ortiz-Andrade R; Estrada-Soto S
    Eur J Med Chem; 2011 Jun; 46(6):2243-51. PubMed ID: 21453996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperglycemic and sub-chronic antidiabetic actions of morolic and moronic acids, in vitro and in silico inhibition of 11β-HSD 1.
    Ramírez-Espinosa JJ; García-Jiménez S; Rios MY; Medina-Franco JL; López-Vallejo F; Webster SP; Binnie M; Ibarra-Barajas M; Ortiz-Andrade R; Estrada-Soto S
    Phytomedicine; 2013 May; 20(7):571-6. PubMed ID: 23453304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
    Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
    Kumar A; Ahmad P; Maurya RA; Singh AB; Srivastava AK
    Eur J Med Chem; 2009 Jan; 44(1):109-16. PubMed ID: 18436346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
    Gupta S; Pandey G; Rahuja N; Srivastava AK; Saxena AK
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5732-4. PubMed ID: 20797859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase 1B inhibitory activity of alkaloids from Rhizoma Coptidis and their molecular docking studies.
    Choi JS; Ali MY; Jung HA; Oh SH; Choi RJ; Kim EJ
    J Ethnopharmacol; 2015 Aug; 171():28-36. PubMed ID: 26027757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
    Zhang L; Jia X; Dong J; Chen D; Liu J; Zhang L; Wen X
    Chem Biol Drug Des; 2014 Mar; 83(3):297-305. PubMed ID: 24119242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies.
    Saxena AK; Pandey G; Gupta S; Singh AB; Srivastava AK
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2320-3. PubMed ID: 19282172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of oleanolic acid derivatives as PTP1B inhibitors.
    Liu QC; Guo TT; Zhang L; Yu Y; Wang P; Yang JF; Li YX
    Eur J Med Chem; 2013 May; 63():511-22. PubMed ID: 23531458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2,7-Substituted (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor γ Partial Agonists with Protein-Tyrosine Phosphatase 1B Inhibition.
    Otake K; Azukizawa S; Takeda S; Fukui M; Kawahara A; Kitao T; Shirahase H
    Chem Pharm Bull (Tokyo); 2015; 63(12):998-1014. PubMed ID: 26633022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Qian S; Li H; Chen Y; Zhang W; Yang S; Wu Y
    J Nat Prod; 2010 Nov; 73(11):1743-50. PubMed ID: 20964318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.